Nutex Health Past Earnings Performance
Past criteria checks 0/6
Nutex Health's earnings have been declining at an average annual rate of -32.5%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 2.5% per year.
Key information
-32.5%
Earnings growth rate
-71.4%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 2.5% |
| Return on equity | -40.6% |
| Net Margin | -14.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Health Check: How Prudently Does Nutex Health (NASDAQ:NUTX) Use Debt?
Jan 24
Nutex Health Inc. (NASDAQ:NUTX) Might Not Be As Mispriced As It Looks
Dec 25Nutex Health Inc. (NASDAQ:NUTX) Just Reported, And Analysts Assigned A US$2.75 Price Target
Aug 12Nutex Health Inc.'s (NASDAQ:NUTX) 30% Cheaper Price Remains In Tune With Revenues
Apr 17Nutex Health GAAP EPS of -$0.03, revenue of $58.05M
Aug 23Revenue & Expenses Breakdown
How Nutex Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 292 | -41 | 40 | 0 |
| 30 Jun 24 | 276 | -38 | 36 | 0 |
| 31 Mar 24 | 259 | -41 | 36 | 0 |
| 31 Dec 23 | 248 | -46 | 36 | 0 |
| 30 Sep 23 | 232 | -29 | 29 | 0 |
| 30 Jun 23 | 197 | -436 | 28 | 0 |
| 31 Mar 23 | 196 | -451 | 22 | 0 |
| 31 Dec 22 | 219 | -425 | 20 | 0 |
| 30 Sep 22 | 229 | -396 | 19 | 0 |
| 30 Jun 22 | 319 | 70 | 17 | 0 |
| 31 Mar 22 | 336 | 122 | 16 | 0 |
| 31 Dec 21 | 332 | 133 | 5 | 0 |
| 30 Sep 21 | 374 | 159 | 25 | 0 |
| 31 Dec 20 | 274 | 106 | 10 | 0 |
| 31 Dec 19 | 97 | 21 | 20 | 0 |
Quality Earnings: NUTX is currently unprofitable.
Growing Profit Margin: NUTX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NUTX is unprofitable, and losses have increased over the past 5 years at a rate of 32.5% per year.
Accelerating Growth: Unable to compare NUTX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NUTX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: NUTX has a negative Return on Equity (-40.62%), as it is currently unprofitable.